CausalSentinel

Protein Dossier — FUT3 (3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: asthma 0.0289 0.00871 9.03e-04 Wald ratio 1 cis NA
Cancer code self-reported: malignant melanoma -0.138 0.0417 9.35e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis -0.0758 0.024 0.00163 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0237 0.00821 0.00391 Wald ratio 1 cis NA
Diagnoses - main ICD10: K60 Fissure and fistula of anal and rectal regions 0.119 0.0421 0.00472 Wald ratio 1 cis NA
Fractured bone site(s): Wrist -0.069 0.0245 0.00484 Wald ratio 1 cis NA
Diagnoses - main ICD10: S66 Injury of muscle and tendon at wrist and hand level 0.188 0.0667 0.00493 Wald ratio 1 cis NA
Pulse rate -0.0136 0.00563 0.0158 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia -0.0622 0.0265 0.0187 Wald ratio 1 cis NA
Forced vital capacity (FVC) 0.00601 0.00262 0.022 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.0289 0.0128 0.024 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis -0.0701 0.0323 0.0303 Wald ratio 1 cis NA
…and 72 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4548_4_2 Fucosyltransferase 3 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

210 association rows across 134 traits (207 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Galactoside 3(4)-L-fucosyltransferase levels 2e-739 rs708686 12 GCST90247666 no MR -> candidate analysis
Circulating FAM3B levels 7e-317 rs708686 2 GCST90860227 no MR -> candidate analysis
FAM3B protein levels 2e-306 rs708686 1 GCST90469186 no MR -> candidate analysis
Tumor biomarkers 3e-290 rs3760775 3 GCST001808 no MR -> candidate analysis
Galactoside 3(4)-L-fucosyltransferase levels (FUT3.4548.4.2) 3e-273 rs708686 4 GCST90241216 no MR -> candidate analysis
Serum levels of protein FUT3 1e-258 rs708686 2 GCST90088733 no MR -> candidate analysis
FUT3 or FUT5 protein levels 6e-224 rs28742587 6 GCST90469280 no MR -> candidate analysis
Serum cancer antigen 19.9 levels 2e-179 rs708686 2 GCST009648 no MR -> candidate analysis
Serum levels of protein FUT5 4e-171 rs3760775 2 GCST90088734 no MR -> candidate analysis
Circulating PRSS27 levels 3e-146 rs708686 1 GCST90859759 no MR -> candidate analysis
Circulating CDH17 levels 2e-139 rs708686 2 GCST90860687 no MR -> candidate analysis
MEP1A protein levels 5e-138 rs708686 1 GCST90469887 no MR -> candidate analysis
…and 122 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 159 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
cholelithiasis 0.91 common-variant locus MR: beta=-0.0758, p=0.00163 (cis)
gallstones 0.768 common-variant locus no MR -> candidate analysis
polyp of gallbladder 0.741 common-variant locus no MR -> candidate analysis
Cholecystitis 0.723 common-variant locus no MR -> candidate analysis
idiopathic pulmonary fibrosis 0.559 common-variant locus no MR -> candidate analysis
viral infectious disease 0.56 common-variant locus no MR -> candidate analysis
COVID-19 0.367 common-variant locus no MR -> candidate analysis
benign colon neoplasm 0.306 common-variant locus MR: beta=-0.0327, p=0.242 (cis)
response to COVID-19 vaccine 0.298 common-variant locus no MR -> candidate analysis
age-related macular degeneration 0.234 common-variant locus no MR -> candidate analysis
macular degeneration 0.224 common-variant locus no MR -> candidate analysis
vitamin B deficiency 0.203 common-variant locus no MR -> candidate analysis
vitamin B12 deficiency 0.171 common-variant locus no MR -> candidate analysis
atrophic macular degeneration 0.165 common-variant locus no MR -> candidate analysis
wet macular degeneration 0.165 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3)
gnomAD constraint pLI=NA, LOEUF=NA — Constraint metrics missing; LoF tolerance cannot be judged.
GWAS Catalog 115 unique SNPs / 272 rows
ClinVar 97 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance